Review outlines updated approach to peripheral arterial disease management
A review on peripheral arterial disease (PAD) states that patients with lower limb PAD face high cardiovascular risk, making medical therapy and behaviour modification central to management. The review reports that supervised exercise therapy improves walking capacity in intermittent claudication while avoiding revascularisation risks, and notes that revascularisation is overused in this group despite carrying substantial peri-procedural risks and limited durability; it states such procedures are generally reserved for chronic limb threatening ischaemia, the most severe and limb-threatening form of PAD.
Most relevant for: Patients with peripheral arterial disease, including asymptomatic disease, intermittent claudication, and chronic limb threatening ischaemia.
Read the original at The LancetSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More family medicine updates
- Long-Acting Injectable HIV Therapy Noninferior for Adherence ChallengesOct 15, 2026
- 8-week sofosbuvir-velpatasvir regimen non-inferior to 12 weeks for HCVSep 30, 2026
- Lean MASLD shows milder histology but similar mortality outcomesSep 30, 2026
- Oral GLP-1 orforglipron shows cardiovascular non-inferiority to insulin glargineSep 30, 2026
- Retatrutide produces substantial weight loss in phase 3 diabetes trialSep 29, 2026